Trial · NCT06182098
Intravenous Fluids in Pediatric Migraine
NCT06182098, Not applicable, Unknown, Dayton Children's Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intravenous Fluids in Pediatric Migraine. Trials, record NCT06182098. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06182098
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intravenous Fluids in Pediatric Migraine
- NCT number
- NCT06182098
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 134 participants, estimated
- Lead sponsor
- Dayton Children's Hospital
- Conditions
- Migraine, Migraine in Children
- Interventions
- 1/2 maintenance fluids, Ketorolac, Diphenhydramine, Prochlorperazine, bolus
- First posted
- 2023-12-26
- Last updated
- 2023-12-26
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | One hour change in pain | one hour | Mean change from baseline pain score, taken at one hour from beginning data collection. A 100 mm visual analog scale is used, with a higher score indicating higher pain. A greater change in pain score means more improved pain. |
| Secondary | Two hour change in pain | two hours | Mean change from baseline pain score, taken at two hours from beginning of data collection. A 100 mm visual analog scale is used, with a higher score indicating higher pain. A greater change in pain score means more improved pain. |
| Secondary | length of emergency stay | Through study completion, up to 24 hours after patient enrollment. | Mean duration of emergency department visit, reported in hours. |
| Secondary | return visits | Through study completion, up to 48 hours after completion of study protocol. | percent of patients with additional visits to the emergency department within 48 hours of discharge |
| Secondary | Admission rate | during emergency department visit, up to 24 hours after patient enrollment | Percentage of patients admitted to the hospital for migraine |
| Secondary | Resolution of pain | Through study completion, up to 24 hours after enrollment | Percentage of patients with complete resolution of pain at the time of emergency discharge |
| Secondary | 50% reduction of pain | Through study completion, up to 24 hours after enrollment. Assessed at the time of discharge from the emergency department | Percentage of patients with at least 50% reduction of pain from baseline, at the time of emergency discharge |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06182098
GET https://conductscience.org/api/trials/v1/NCT06182098/registered